Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

PMID:
28891083
2.

Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.

Niioka T, Fujishima N, Abumiya M, Yamashita T, Ubukawa K, Nara M, Fujishima M, Takahashi N, Miura M.

Ther Drug Monit. 2017 Oct;39(5):514-521. doi: 10.1097/FTD.0000000000000441.

PMID:
28834922
3.

Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosis.

Fujishima M, Fujishima N, Kitadate A, Guo Y, Watanabe A, Ubukawa K, Nara M, Yoshioka T, Kameoka Y, Takahashi N.

Rinsho Ketsueki. 2017;58(7):743-748. doi: 10.11406/rinketsu.58.743. Japanese.

PMID:
28781268
4.

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study.

Kantarjian HM, DeAngelo DJ, Advani AS, Stelljes M, Kebriaei P, Cassaday RD, Merchant AA, Fujishima N, Uchida T, Calbacho M, Ejduk AA, O'Brien SM, Jabbour EJ, Zhang H, Sleight BJ, Vandendries ER, Marks DI.

Lancet Haematol. 2017 Aug;4(8):e387-e398. doi: 10.1016/S2352-3026(17)30103-5. Epub 2017 Jul 4.

PMID:
28687420
5.

Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.

Yamashita T, Fujishima N, Miura M, Niioka T, Abumiya M, Shinohara Y, Ubukawa K, Nara M, Fujishima M, Kameoka Y, Tagawa H, Hirokawa M, Takahashi N.

Cancer Chemother Pharmacol. 2016 Jul;78(1):111-8. doi: 10.1007/s00280-016-3060-4. Epub 2016 May 23.

6.

Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation.

Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, Ota S, Moriyama M, Ikezoe T, Miyazaki Y, Hayashi K, Fujita S, Satake A, Ito T, Kyo T, Tanimoto M.

J Blood Med. 2016 Jan 18;7:1-4. doi: 10.2147/JBM.S93008. eCollection 2016.

7.

[Anemia: From Basic Knowledge to Up-to-Date Treatment. Topics: VI. Pathophysiology and management of aplastic anemia and pure red cell aplasia].

Hirokawa M, Fujishima N, Omokawa A, Ueki S.

Nihon Naika Gakkai Zasshi. 2015 Jul 10;104(7):1405-13. Japanese. No abstract available.

PMID:
26513960
8.

[Tension Hemothorax Associated with Spontaneous Rupture of the Thoracic Aorta;Report of a Case].

Yoshida C, Yamamoto Y, Sasa S, Matsuoka H, Hokimoto N, Yamai H, Ohnishi K, Tanida N, Fujishima N, Hamaguchi N, Ichikawa Y, Tano K.

Kyobu Geka. 2015 Aug;68(9):789-92. Japanese.

PMID:
26329715
9.

Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.

Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Fujisawa S, Yonemura Y, Kawano F, Oshimi K, Sugimoto K, Matsuda A, Karasawa M, Arai A, Komatsu N, Harigae H, Omine M, Ozawa K, Kurokawa M; PRCA Collaborative Study Group.

Br J Haematol. 2015 Jun;169(6):879-86. doi: 10.1111/bjh.13376. Epub 2015 Mar 25.

PMID:
25807974
10.

Encapsulated papillary carcinoma, apocrine type, of the breast.

Kuroda N, Fujishima N, Hayes MM, Moritani S, Ichihara S.

Malays J Pathol. 2014 Aug;36(2):139-43. Review.

11.

Treatment of multiple myeloma in Akita: features and outcomes in the era of novel agents.

Shida S, Takahashi N, Niioka T, Kitabayashi A, Kawabata Y, Kume M, Saitoh H, Hatano Y, Ichikawa Y, Kuroki J, Motegi M, Kobayashi T, Kameoka Y, Tagawa H, Fujishima N, Yoshioka T, Hirokawa M, Miura M, Sawada K.

J Clin Exp Hematop. 2014;54(1):89-93. No abstract available.

12.

Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia.

Abumiya M, Takahashi N, Niioka T, Kameoka Y, Fujishima N, Tagawa H, Sawada K, Miura M.

Drug Metab Pharmacokinet. 2014;29(6):449-54. doi: 10.2133/dmpk.DMPK-14-RG-031. Epub 2014 Jun 3.

13.

A limited sampling model to estimate exposure to lenalidomide in multiple myeloma patients.

Shida S, Takahashi N, Miura M, Niioka T, Matsumoto M, Hagihara M, Kobayashi T, Abumiya M, Kameoka Y, Fujishima N, Tagawa H, Hirokawa M, Sawada K.

Ther Drug Monit. 2014 Aug;36(4):505-9. doi: 10.1097/FTD.0000000000000034.

PMID:
24562046
14.

Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.

Nara M, Takahashi N, Miura M, Niioka T, Kagaya H, Fujishima N, Saitoh H, Kameoka Y, Tagawa H, Hirokawa M, Sawada K.

Eur J Clin Pharmacol. 2013 Jun;69(6):1321-9. doi: 10.1007/s00228-013-1471-2. Epub 2013 Jan 26.

PMID:
23354810
15.

[Case report; Fibrinoid necrotizing angiitis of the gall bladder in a patient with systemic lupus erythematosus].

Ikeda S, Komatsuda A, Togashi M, Yamashita T, Michishita Y, Fujishima M, Fujishima N, Wakui H, Sawada K.

Nihon Naika Gakkai Zasshi. 2012 Nov 10;101(11):3229-32. Japanese. No abstract available.

PMID:
23342596
16.

[Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].

Nagao T, Takahashi N, Saitoh H, Noguchi S, Guo YM, Ito M, Watanabe A, Fujishima N, Kameoka Y, Tagawa H, Hirokawa M, Sawada K.

Rinsho Ketsueki. 2012 Dec;53(12):2008-12. Japanese.

PMID:
23318967
17.

CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia.

Michishita Y, Hirokawa M, Fujishima N, Abe Y, Fujishima M, Guo YM, Ubukawa K, Liu J, Yoshioka T, Kameoka Y, Saitoh H, Tagawa H, Takahashi N, Sawada K.

Immunol Lett. 2013 Feb;150(1-2):23-9. doi: 10.1016/j.imlet.2012.12.006. Epub 2012 Dec 27.

PMID:
23274961
18.

Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.

Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T.

Anticancer Drugs. 2013 Mar;24(3):310-4. doi: 10.1097/CAD.0b013e32835c401c.

PMID:
23237922
19.

Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia.

Noguchi S, Takahashi N, Ito M, Teshima K, Yamashita T, Michishita Y, Ohyagi H, Shida S, Nagao T, Fujishima M, Ikeda S, Ito I, Fujishima N, Kameoka Y, Saitoh H, Tagawa H, Hirokawa M, Sawada K.

Int J Clin Oncol. 2013 Dec;18(6):983-7. doi: 10.1007/s10147-012-0485-6. Epub 2012 Oct 18.

PMID:
23076821
20.

Comparison of autologous hematopoietic cell transplantation and chemotherapy as postremission treatment in non-M3 acute myeloid leukemia in first complete remission.

Usuki K, Kurosawa S, Uchida N, Yakushiji K, Waki F, Matsuishi E, Kagawa K, Furukawa T, Maeda Y, Shimoyama M, Ago H, Yamano Y, Yano S, Fujishima N, Takamatsu Y, Eto T, Hidaka M, Matsuoka H, Fukuda T.

Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):444-51. doi: 10.1016/j.clml.2012.07.004. Epub 2012 Sep 20.

PMID:
22999942
21.

A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells.

Liu J, Guo YM, Hirokawa M, Iwamoto K, Ubukawa K, Michishita Y, Fujishima N, Tagawa H, Takahashi N, Xiao W, Yamashita J, Ohteki T, Sawada K.

Exp Hematol. 2012 Apr;40(4):330-41. doi: 10.1016/j.exphem.2011.12.002. Epub 2011 Dec 20.

PMID:
22198151
22.

False-positive human immunodeficiency virus antibody test and autoimmune hemolytic anemia in a patient with angioimmunoblastic T-cell lymphoma.

Shida S, Takahashi N, Fujishima N, Kameoka Y, Nara M, Fujishima M, Saitoh H, Tagawa H, Hirokawa M, Ichinohasama R, Sawada K.

Intern Med. 2011;50(20):2383-7. Epub 2011 Oct 15.

23.

Successful treatment of necrotizing fasciitis in an upper extremity caused by Clostridium perfringens after bone marrow transplantation.

Ito M, Takahashi N, Saitoh H, Shida S, Nagao T, Kume M, Kameoka Y, Tagawa H, Fujishima N, Hirokawa M, Tazawa H, Minato T, Yamada S, Sawada K.

Intern Med. 2011;50(19):2213-7. Epub 2011 Oct 1.

24.

Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.

Michishita Y, Hirokawa M, Guo YM, Abe Y, Liu J, Ubukawa K, Fujishima N, Fujishima M, Yoshioka T, Kameoka Y, Saito H, Tagawa H, Takahashi N, Sawada K.

Int J Hematol. 2011 Sep;94(3):230-240. doi: 10.1007/s12185-011-0907-7. Epub 2011 Aug 20.

PMID:
21858446
25.

Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient.

Miura M, Takahashi N, Kanno S, Kato S, Nara M, Itoh M, Saitoh H, Yoshioka T, Kameoka Y, Fujishima N, Tagawa H, Hirokawa M, Sawada K.

Clin Chim Acta. 2011 Oct 9;412(21-22):2002-6. doi: 10.1016/j.cca.2011.06.035. Epub 2011 Jul 21.

PMID:
21771587
26.

Fatal hemorrhagic pneumonia caused by Stenotrophomanas maltophilia in a patient with non-Hodgkin lymphoma.

Takahashi N, Yoshioka T, Kameoka Y, Tagawa H, Fujishima N, Saitoh H, Hirokawa M, Enomoto K, Sawada K.

J Infect Chemother. 2011 Dec;17(6):858-62. doi: 10.1007/s10156-011-0261-y. Epub 2011 Jun 9.

PMID:
21656194
27.

Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms.

Nara M, Komatsuda A, Fujishima M, Fujishima N, Nara M, Iino T, Ito H, Sawada K, Wakui H.

Clin Exp Nephrol. 2011 Aug;15(4):582-5. doi: 10.1007/s10157-011-0436-y. Epub 2011 Mar 24. Review.

PMID:
21431897
28.

Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.

Takahashi N, Kameoka Y, Tagawa H, Saitoh H, Yoshioka T, Fujishima N, Kitabayashi A, Takahashi K, Hirokawa M, Sawada K.

Int J Hematol. 2010 Oct;92(3):559-61. doi: 10.1007/s12185-010-0679-5. Epub 2010 Sep 14. No abstract available.

PMID:
20838959
29.

[Pathophysiology and treatment of large granular lymphocyte leukemia-associated pure red cell aplasia].

Fujishima N.

Rinsho Ketsueki. 2010 Aug;51(8):589-96. Review. Japanese. No abstract available.

PMID:
20805663
30.

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.

Takahashi N, Miura M, Scott SA, Kagaya H, Kameoka Y, Tagawa H, Saitoh H, Fujishima N, Yoshioka T, Hirokawa M, Sawada K.

J Hum Genet. 2010 Nov;55(11):731-7. doi: 10.1038/jhg.2010.98. Epub 2010 Aug 19.

PMID:
20720558
31.

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.

Kurosawa S, Yamaguchi T, Miyawaki S, Uchida N, Sakura T, Kanamori H, Usuki K, Yamashita T, Okoshi Y, Shibayama H, Nakamae H, Mawatari M, Hatanaka K, Sunami K, Shimoyama M, Fujishima N, Maeda Y, Miura I, Takaue Y, Fukuda T.

Haematologica. 2010 Nov;95(11):1857-64. doi: 10.3324/haematol.2010.027516. Epub 2010 Jul 15.

32.

A simple, sensitive high-performance liquid chromatography -ultraviolet method for the quantification of concentration and steady-state pharmacokinetics of itraconazole and hydroxyitraconazole.

Miura M, Takahashi N, Nara M, Fujishima N, Kagaya H, Kameoka Y, Saitoh H, Tagawa H, Sawada K.

Ann Clin Biochem. 2010 Sep;47(Pt 5):432-9. doi: 10.1258/acb.2010.010029. Epub 2010 Jul 1.

PMID:
20595406
33.

Effects of alpha-glucosylhesperidin on the peripheral body temperature and autonomic nervous system.

Takumi H, Fujishima N, Shiraishi K, Mori Y, Ariyama A, Kometani T, Hashimoto S, Nadamoto T.

Biosci Biotechnol Biochem. 2010;74(4):707-15. Epub 2010 Apr 7.

34.

Solid papillary carcinoma of the breast: imprint cytological and histological findings.

Kuroda N, Fujishima N, Inoue K, Ohara M, Mizuno K, Lee GH.

Med Mol Morphol. 2010 Mar;43(1):48-52. doi: 10.1007/s00795-009-0444-0. Epub 2010 Mar 26.

PMID:
20340006
35.

Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.

Guo YM, Hirokawa M, Takahashi N, Fujishima M, Fujishima N, Komatsuda A, Tagawa H, Ohyagi H, Michishita Y, Ubukawa K, Hebiguchi M, Xiao W, Sawada K.

Int J Hematol. 2010 Jan;91(1):61-8. doi: 10.1007/s12185-009-0456-5. Epub 2009 Dec 12.

PMID:
20012512
36.

A case of intravascular large B-cell lymphoma of the cutaneous variant: the first case in Asia.

Kameoka Y, Takahashi N, Tagawa H, Fujishima N, Yoshioka T, Saito H, Hirokawa M, Ichinohasama R, Sawada K.

Int J Hematol. 2010 Jan;91(1):146-8. doi: 10.1007/s12185-009-0458-3. Epub 2009 Dec 12. No abstract available.

PMID:
20012511
37.

The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma.

Kuroda N, Ohara M, Inoue K, Mizuno K, Fujishima N, Hamaguchi N, Lee GH.

Med Mol Morphol. 2009 Jun;42(2):128-31. doi: 10.1007/s00795-008-0428-5. Epub 2009 Jun 18.

PMID:
19536621
38.

Diagnosis and management of acquired pure red cell aplasia.

Sawada K, Hirokawa M, Fujishima N.

Hematol Oncol Clin North Am. 2009 Apr;23(2):249-59. doi: 10.1016/j.hoc.2009.01.009. Review.

PMID:
19327582
39.

Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, Watanabe T, Arai A, Matsui T, Nakao S, Urabe A, Omine M, Ozawa K.

Am J Hematol. 2009 Mar;84(3):144-8. doi: 10.1002/ajh.21354.

40.

Coexistent adenomyoepithelioma and invasive ductal carcinoma of the breast: presentation as separate tumors.

Kuroda N, Fujishima N, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH.

Med Mol Morphol. 2008 Dec;41(4):238-42. doi: 10.1007/s00795-008-0376-0. Epub 2008 Dec 24.

PMID:
19107615
41.

Dynamics of human erythroblast enucleation.

Hebiguchi M, Hirokawa M, Guo YM, Saito K, Wakui H, Komatsuda A, Fujishima N, Takahashi N, Takahashi T, Sasaki T, Nunomura W, Takakuwa Y, Sawada K.

Int J Hematol. 2008 Dec;88(5):498-507. doi: 10.1007/s12185-008-0200-6. Epub 2008 Dec 2.

PMID:
19043811
42.

Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.

Fujishima N, Sawada K, Hirokawa M, Oshimi K, Sugimoto K, Matsuda A, Teramura M, Karasawa M, Arai A, Yonemura Y, Nakao S, Urabe A, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2008 Oct;93(10):1555-9. doi: 10.3324/haematol.12871. Epub 2008 Jul 18.

43.

Basal-like carcinoma of the breast: further evidence of the possibility that most metaplastic carcinomas may be actually basal-like carcinomas.

Kuroda N, Fujishima N, Inoue K, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH.

Med Mol Morphol. 2008 Jun;41(2):117-20. doi: 10.1007/s00795-007-0379-2. Epub 2008 Jul 1.

PMID:
18592167
44.

Acquired pure red cell aplasia: updated review of treatment.

Sawada K, Fujishima N, Hirokawa M.

Br J Haematol. 2008 Aug;142(4):505-14. doi: 10.1111/j.1365-2141.2008.07216.x. Epub 2008 May 28. Review.

45.

Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha.

Saito Y, Guo YM, Hirokawa M, Saito K, Komatsuda A, Takahashi N, Fujishima M, Fujishima N, Yamashita J, Sawada K.

Int J Hematol. 2008 Jul;88(1):64-72. doi: 10.1007/s12185-008-0098-z. Epub 2008 May 20.

PMID:
18484240
46.

Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma.

Takahashi N, Kameoka Y, Yamanaka Y, Ubukawa K, Saito K, Fujishima M, Fujishima N, Saito H, Hirokawa M, Scott SA, Sawada K.

Intern Med. 2008;47(7):651-3. Epub 2008 Apr 1.

47.

Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.

Hirokawa M, Sawada K, Fujishima N, Nakao S, Urabe A, Dan K, Fujisawa S, Yonemura Y, Kawano F, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2008 Jan;93(1):27-33. doi: 10.3324/haematol.11655.

48.

Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.

Hirokawa M, Kawabata Y, Fujishima N, Yoshioka T, Sawada K.

Int J Hematol. 2007 Oct;86(3):291-2. No abstract available.

PMID:
17989001
49.

Anaplastic carcinoma of the pancreas with rhabdoid features and hyaline globule-like structures.

Kuroda N, Iwamura S, Fujishima N, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Lee GH.

Med Mol Morphol. 2007 Sep;40(3):168-71. Epub 2007 Sep 18.

PMID:
17874050
50.

Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, Tsurumi H, Nakao S, Urabe A, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2007 Aug;92(8):1021-8. Epub 2007 Jul 20.

Supplemental Content

Loading ...
Support Center